76 related articles for article (PubMed ID: 20038061)
1. [Value of auto-fluorescence spectrum combined with tumor markers in diagnosis of lung cancer].
Wu YJ; Hao YH; Wu WC; Wu YM
Guang Pu Xue Yu Guang Pu Fen Xi; 2009 Oct; 29(10):2787-91. PubMed ID: 20038061
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis and prediction of lung cancer through different classification techniques with tumor markers].
Nie GJ; Feng FF; Wu YJ; Wu YM
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2009 May; 27(5):257-61. PubMed ID: 19538834
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of pancreatic carcinoma based on combined measurement of multiple serum tumor markers using artificial neural network analysis.
Yang Y; Chen H; Wang D; Luo W; Zhu B; Zhang Z
Chin Med J (Engl); 2014; 127(10):1891-6. PubMed ID: 24824251
[TBL] [Abstract][Full Text] [Related]
4. The concentration of CYFRA 21-1, NSE and CEA in cerebro-spinal fluid can be useful indicators for diagnosis of meningeal carcinomatosis of lung cancer.
Wang P; Piao Y; Zhang X; Li W; Hao X
Cancer Biomark; 2013; 13(2):123-30. PubMed ID: 23838141
[TBL] [Abstract][Full Text] [Related]
5. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].
Chen F; Li WM; Wang DM; Gao SS; Bao Y; Chen WB; Liu D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):832-5. PubMed ID: 19024326
[TBL] [Abstract][Full Text] [Related]
6. [Comparison and analysis of three classifying models for discrimination of lung cancer established by 6 tumor markers].
Feng F; Nie G; Wu Y; Wu Y
Wei Sheng Yan Jiu; 2009 Jul; 38(4):429-32. PubMed ID: 19689074
[TBL] [Abstract][Full Text] [Related]
7. Classification of individual lung cancer cell lines based on DNA methylation markers: use of linear discriminant analysis and artificial neural networks.
Marchevsky AM; Tsou JA; Laird-Offringa IA
J Mol Diagn; 2004 Feb; 6(1):28-36. PubMed ID: 14736824
[TBL] [Abstract][Full Text] [Related]
8. Utility of squamous cell carcinoma antigen, carcinoembryonic antigen, Cyfra 21-1 and neuron specific enolase in lung cancer diagnosis: a prospective study from China.
Song WA; Liu X; Tian XD; Wang W; Liang CY; Zhang T; Guo JT; Peng YH; Zhou NK
Chin Med J (Engl); 2011 Oct; 124(20):3244-8. PubMed ID: 22088515
[TBL] [Abstract][Full Text] [Related]
9. [Study on the value of tumor markers ProGRP, CYFRA21-1, NSE and CEA in the differential diagnosis of pleural effusion].
Liu Y; Yu L; Lin J
Zhongguo Fei Ai Za Zhi; 2006 Jun; 9(3):273-6. PubMed ID: 21172161
[TBL] [Abstract][Full Text] [Related]
10. Application of artificial neural network model combined with four biomarkers in auxiliary diagnosis of lung cancer.
Duan X; Yang Y; Tan S; Wang S; Feng X; Cui L; Feng F; Yu S; Wang W; Wu Y
Med Biol Eng Comput; 2017 Aug; 55(8):1239-1248. PubMed ID: 27766520
[TBL] [Abstract][Full Text] [Related]
11. The effect of artificial neural network model combined with six tumor markers in auxiliary diagnosis of lung cancer.
Feng F; Wu Y; Wu Y; Nie G; Ni R
J Med Syst; 2012 Oct; 36(5):2973-80. PubMed ID: 21882004
[TBL] [Abstract][Full Text] [Related]
12. [The value of serum tumor marker in the diagnosis of lung cancer].
Shi GL; Hu XL; Yue SD; Song CX
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):299-301. PubMed ID: 15996327
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
Li CS; Cheng BC; Ge W; Gao JF
Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612
[TBL] [Abstract][Full Text] [Related]
14. Comparison of artificial neural network analysis with other multimarker methods for detecting genetic association.
Curtis D
BMC Genet; 2007 Jul; 8():49. PubMed ID: 17640352
[TBL] [Abstract][Full Text] [Related]
15. Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic masses.
Zhang Z; Barnhill SD; Zhang H; Xu F; Yu Y; Jacobs I; Woolas RP; Berchuck A; Madyastha KR; Bast RC
Gynecol Oncol; 1999 Apr; 73(1):56-61. PubMed ID: 10094881
[TBL] [Abstract][Full Text] [Related]
16. The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited.
Ma S; Shen L; Qian N; Chen K
Cancer Biomark; 2011-2012; 10(3-4):155-62. PubMed ID: 22674301
[TBL] [Abstract][Full Text] [Related]
17. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
Pan QR; Zhang X; Xu ZF; Zheng S
Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076
[TBL] [Abstract][Full Text] [Related]
18. [The clinical diagnosis value of fibro-optic bronchoscope examination combined with tumor marker determination to lung cancer].
Yang YJ; Cheng DY; Fang X; Li XX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 38(2):312-5. PubMed ID: 17441358
[TBL] [Abstract][Full Text] [Related]
19. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320
[TBL] [Abstract][Full Text] [Related]
20. Fuzzy logic-based tumor-marker profiles improved sensitivity in the diagnosis of lung cancer.
Schneider J; Bitterlich N; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
Int J Clin Oncol; 2002 Jun; 7(3):145-51. PubMed ID: 12109515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
